Orange Book product · Generic (ANDA)
CLADRIBINE
CLADRIBINE
At a glance
Oct 06, 2011
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 06, 2011
14 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
CLADRIBINE
Strength
1MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 200510
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLADRIBINE
- 2019MAVENCLADBrand (NDA)
NDA 022561 · EMD SERONO INC
- 1993LEUSTATINBrand (NDA)
NDA 020229 · JANSSEN PHARMS
- 2026CLADRIBINEGeneric (ANDA)
ANDA 215547 · HOPEWELL PHARMA
- 2025CLADRIBINEGeneric (ANDA)
ANDA 218425 · APOTEX
- 2019CLADRIBINEGeneric (ANDA)
ANDA 210856 · HISUN PHARM HANGZHOU
- 2004CLADRIBINEGeneric (ANDA)
ANDA 076571 · FRESENIUS KABI USA
- 2000CLADRIBINEGeneric (ANDA)
ANDA 075405 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
